Ultralight Labs
NYC-based Ultralight Labs accelerates medical device innovation with a streamlined, compliance-focused software platform.
Founded
2022NYC-based Ultralight Labs accelerates medical device innovation with a streamlined, compliance-focused software platform.
Founded in New York City, Ultralight Labs accelerates medical device innovation by providing a streamlined software platform focused on compliance and operational efficiency. Their core mission is to simplify the complex and time-consuming aspects of medical device development, offering a lightweight solution for requirements and risk management, end-to-end traceability, and related compliance activities. This platform is optimized for the fast-paced nature of modern device development, targeting medtech companies looking to enhance their product development workflows.
Notable affiliated people and investors include key figures in the medical technology and software development sectors, although specific names are not publicly disclosed. Ultralight Labs has achieved significant milestones in improving the efficiency of medical device development processes, earning recognition for their innovative approach to compliance and operational streamlining. Their impact is evident in the accelerated timelines and reduced complexities experienced by their clients, positioning Ultralight Labs as a crucial player in the medtech industry.
Companies similar to Ultralight Labs include Nemedio, uLink Labs, Essenvia and Ketryx.
Ultralight Labs was founded in 2022.
Ultralight Labs' headquarters is located in New York City, NY, US.
Ultralight Labs' most recent funding round was for $2.7M (USD) in July 2023.
As of Jul 21, 2023, Ultralight Labs has disclosed funding of $2.7M (USD). Undisclosed round amounts are excluded.
Ultralight Labs has 6 employees as of Feb 5, 2024.
Ketryx
ketryx.com
